Pharvaris N.V. has released its Annual Report for the fiscal year ending December 31, 2024. The report details the company's business activities, organizational structure, and operating results. It highlights the company's ongoing focus on research and development, which has been its principal expenditure since inception. Pharvaris has primarily financed its operations through the issuance of equity securities. The report also covers various risk factors and controls and procedures in place. The full report can be accessed through the link below.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.